Joint damage in hiv positive patients
https://doi.org/10.21518/2079-701X-2018-9-82-87
Abstract
Nowadays, HIV infection remains one of the major threats to global public health. The clinical signs of HIV infection are extremely diverse and associated with many, including rheumatic diseases. This review examines the issue of osteoarticular disorders in HIV positive patients. The article presents a detailed clinical description of individual nosological forms (HIVassociated arthritis, reactive arthritis, psoriatic arthritis, etc.) and considers the issues of differential diagnosis of these diseases. Modern approaches to the treatment of inflammatory joint diseases in HIV infection, including genetic engineering biological preparations are analysed.
About the Authors
D. V. Bukhanova
V.A. Nasonova Research Institute of Reumatology, FBGNU В.А.
Russian Federation
Russian Federation
Moscow
B. S. Belov
V.A. Nasonova Research Institute of Reumatology, FBGNU В.А.
Russian Federation
Russian Federation
Moscow
References
1. Данные на сайте: http://www.who.int/mediacentre/factsheets/fs360/ru.
2. Данные на сайте: www.aids-centr.perm.ru.
3. Duvic M, Johnson TM, Rapini RP et al. Acquired immunodeficiency syndrome-associated psoriasis and Reiter’s syndrome. Arch Dermatol, 1987, 123: 1622–32.
4. Berman A, Espinoza LR, Diaz JD, Aguilar JL. Rheumatic manifestations of human immunodeficiency virus infection. Am J Med, 1988, 85(1): 59-64.
5. Yao Q, Frank M, Glynn M, Altman RD. Rheumatic manifestations in HIV-1 infected in-patients and literature review. Clin Exp Rheumatol, 2008, 26(5): 799-806.
6. Fox C, Walker-Bone K. Evolving spectrum of HIV-associated rheumatic syndromes. Best Pract Res Clin Rheumatol, 2015 Apr, 29(2): 244-58.
7. Chiowchanwisawakit P, Koolvisoot A, Ratanasuwan W, Suwanagool S. Prevalence of rheumatic disease in HIV infected Thai patients. J Med Assoc Thai, 2005, 88(12): 1775-81.
8. Reveille JD. Rheumatic manifestations of human immunodeficiency virus infection. In: Kelley and Firestein’s Textbook of Rheumatology. 10th edition. Eds. GS Firestein, RC Budd, G Sherin, JB Mcinnes, JR O’Dell. Elsevier, Philadelphia. 2017: 1929-1942.
9. Mody GM, Parke FA, Reveille JD. Articular manifestations of human immunodeficiency virus infection. Best Pract Res Clin Rheumatol, 2003, 17: 265–287.
10. Hochberg MC, Fox R, Nelson KE, Saah A. HIV infection is not associated with Reiter’s syndrome: data from the Johns Hopkins Multi center AIDS Cohort Study. AIDS, 1990, 4(11): 1149-51.
11. Clark MR, Solinger AM, Hochberg MC. Human immunodeficiency virus infection is not associated with Reiter’s syndrome. Data from three large cohort studies. Rheum Dis Clin North Am, 1992, 18(1): 267-276.
12. Monteagudo I, Rivera J, Lopez-Longo J. AIDS and rheumatic manifestations in patients addicted to drugs. An analysis of 106 cases. J Rheumatol, 1991, 18: 1038–41.
13. Marquez J, Restrepo CS, Candia L. Human immunodeficiency virus-associated rheumatic disorders in the HAART era. J Rheumato, 2004, 31: 741–6.
14. Lawson E, Walker-Bone K. The changing spectrum of rheumatic disease in HIV infection. Br Med Bull, 2012, 103(1): 203-21.
15. Njobvu P, McGill P: Human immunodeficiency virus related reactive arthritis in Zambia. J Rheumatol, 2005, 32: 1299–1304.
16. Medina F, Jara LJ, Miranda JM, et al. Successful outcome in HIV patients with Reiter’s syndrome treated with bromocriptine. Arthritis Rheum. 1993, 36: 727–8.
17. Calabrese LH, O’Connell M, Kelley DM, et al. A longitudinal study of patients infected with the human immunodeficiency virus (HIV). The influence of rheumatic symptoms on the natural history of retroviral infections. Arthritis Rheum, 1991, 34: 257–63.
18. Reveille JD, Conant MA, Duvic M. Human immunodeficiency virus-associated psoriasis, psoriatic arthritis, and Reiter’s syndrome: a disease continuum? Arthritis Rheum, 1990 Oct, 33(10): 1574-8.
19. Scott C, Brand A, Natha M. Reactive arthritis responding to antiretroviral therapy in an HIV1-infected individual. Int J STD AIDS, 2012, 23(5): 373-4.
20. Solinger AM, Hess EV. Rheumatic diseases and AIDS – is the association real? J Rheumatol, 1993 Apr, 20(4): 678-83.
21. Buskila D, Gladman D. Musculoskeletal manifestations of infection with human immunodeficiency virus. Rev Infect Dis, 1990 Mar-Apr, 12(2): 223-35.
22. Calabrese LH, Kirchner E, Shrestha R. Rheumatic complications of human immunodeficiency virus infection in the era of highly active antiretroviral therapy: emergence of a new syndrome of im mune reconstitution and changing patterns of disease. Semin Arthritis Rheum, 2005, 35(3): 166-74.
23. Mallon E, Bunker CB. HIV-associated psoriasis. AIDS. Patient Care & Stds, 2000, 14: 239-46.
24. Maurer TA, Zackheim HS, Tuffanelli L, et al. The use of methotrexate for treatment of psoriasis in patients with HIV infection. J Am Acad Dermatol, 1994, 31: 372–375.
25. Rieger A, Minsue Chen T, Cockerell CJ. Cutaneous Manifestations of HIV Infection and HIV-related Disorders. In: Dermatology, 3rd ed. Eds. Bolognia JL, Jorizzo JL, Schaffer JV. Elsevier, Amsterdam. 2012: 1285-1302.
26. Njobvu P, McGill P. Psoriatic arthritis and human immunodeficiency virus infection in Zambia. J Rheumatol, 2000, 27(7): 1699-702.
27. Castillo RL, Racaza GZ, Roa FD. Ostraceous and inverse psoriasis with psoriatic arthritis as the presenting features of advanced HIV infection. Singapore Med J, 2014, 55(4): e60-3.
28. Montazeri A, Kanitakis J, Bazex J. Psoriasis and HIV infection. Int J Dermatol, 1996, 35: 475-9.
29. Bartlett BL, Khambaty M, Mendoza N, et al. Dermatological management of human immunodeficiency virus. Skin Therapy Lett, 2007, 12: 1-3.
30. Morar N, Willis-Owen SA, Maurer T, Bunker CB. HIV-associated psoriasis: pathogenesis, clinical features and management. Lancet Infect Dis, 2010, 10: 470–478.
31. Adizie T, Moots RJ, Hodkinson B, et al. Inflammatory arthritis in HIV positive patients: A practical guide. BMC Infect Dis. 2016 , 16: 100.
32. Rosenberg ZS, Norman A, Solomon G. Arthritis associated with HIV infection: radiographic manifestations. Radiology, 1989, 173(1): 171-6.
33. Kole AK, Roy R, Kole DC. Musculoskeletal and rheumatological disorders in HIV infection: Experience in a tertiary referral center. Indian J Sex Transm Dis, 2013 Jul, 34(2): 107-12.
34. Ouédraogo DD, Ntsiba H, Tiendrébéogo Zabsonré J et al. Clinical spectrum of rheumatologic diseases in a department of rheumatology in Ouagadougou (Burkina Faso). Clin Rheumatol, 2014, 33(3): 385-9.
35. Iordache L, Launay O, Bouchaud O,et al. Autoim mune diseases in HIV-infected patients: 52 cases and literature review. Autoimmun Rev, 2014, 13(8): 850-7.
36. Cunha BM, Mota LM, Pileggi GS,et al. HIV/AIDS and rheumatoid arthritis. Autoimmun Rev, 2015, 14(5): 396-400.
37. Lebrun D, Hentzien M, Cuzin L,et al. Epidemiology of autoimmune and inflammatory diseases in a French nationwide HIV cohort. AIDS, 2017, 31(15): 2159-2166.
38. Stein CM, Davis P. Arthritis associated with HIV infection in Zimbabwe. J Rheumatol, 1996, 23(3): 506-11.
39. Azeroual A, Harmouche H, Benjilali L et al. Rheumatoid arthritis associated to HIV infection. Eur J Intern Med, 2008 Oct, 19(6): e34-5.
40. Siva C, Brasington RD. Worsening of arthritis with antiretroviral therapy: the coexistence of rheumatoid arthritis and human immunodeficiency virus infection revisited. J Clin Rheumatol, 2001 Feb, 7(1): 42-6.
41. Ndakotsu MA, Salawu L, Durosinmi MA. Relation between erythrocyte sedimentation rate, clinical and immune status in HIV-infected patients. Niger J Med, 2009, 18(2): 208-10.
42. Jackson S, Tarkowski A, Collins JE, et al. Occurrence of polymeric IgA rheumatoid factor in the acquired immune deficiency syndrome. J Clin Immunol, 1988, 8: 390–6.
43. Silva AF, Matos AN, Lima AMS, et al. Valor diagnóstico do anticorpo antipeptídeo citrulinado cíclico na artrite reumatóide. Rev Bras Reumatol, 2006, 46: 174–80.
44. du Toit R, Whitelaw D, Taljaard JJ, et al. Lack of specificity of anticyclic citrullinated peptide antibodies in advanced human immunodeficiency virus infection. J Rheumatol, 2011, 38: 1055–60.
45. Telles JP, Azevedo Grande M, Jurgensen A, et al .Rheumatic manifestations in brazilian patients with AIDS. Acta Reumatol Port, 2014, 39: 143–5.
46. Massabki PS, Accetturi C, Nishie IA, et al. Clinical implications of autoantibodies in HIV infection. AIDS, 1997, 11: 1845-50
47. Allison GT, Bostrom MP, Glesby MJ Osteonecrosis in HIV disease: epidemiology, etiologies, and clinical management. AIDS, 2003, 17: 1–9.
48. Morse CG, Mican JM, Jones EC, Joe G.O., et al. The incidence and natural history of osteonecrosis in HIV–infected adults. Clin Infect Dis, 2007, 44: 739–748.
49. Mehsen-Cêtre N, Cazanave C. Osteoarticular manifestations associated with HIV infection. Joint Bone Spine, 2017, 84(1): 29-33.
50. Belzunegui J, Santisteban M, Gorordo M, et al. Osteoarticular mycobacterial infections in patients with the human immunodeficiency virus. Clin Exp Rheumatol, 2004, 22: 343–345.
51. Louthrenoo W. Rheumatic manifestations of human immunodeficiency virus infection. Curr Opin Rheumatol, 2008, 20: 92–99.
52. Newton L, van Halsema C, Snowden N. HIV and rheumatology: a practical guide. ARUK Topical Reviews, Issue 5, Autumn, 2014.
53. Bourinbaiar AS, Lee-Huang S. The non-steroidal anti-inflammatory drug, indomethacin, as an inhibitor of HIV replication. FEBS Lett, 1995, 360: 85–88.
54. Njobvu PD, McGill PE. Sulphasalazine in the treatment of HIV related spondyloarthropathy. Br J Rheumatol, 1997, 36: 403–404.
55. Chiang G, Sassaroli M, Louie M, et al. Inhibition of HIV-1 replication by hydroxychloroquine: mechanism of action and comparison with zidovudine. Clin Ther, 1996, 18: 1080–1092.
56. Louthrenoo W. Successful treatment of severe Reiter’s syndrome associated with human immunodeficiency virus infection with etretinate: report of 2 cases. J Rheumatol, 1993, 20: 1243–1246.
57. Cepeda EJ, Williams FM, Ishimori ML, et al. The use of anti-tumor necrosis factor therapy in HIV-positive individuals with rheumatic disease. Ann Rheum Dis, 2008, 67: 710–712.
58. Wangsiricharoen S, Ligon C, Gedmintas L et al. Rates of Serious Infections in HIV-Infected Patients Receiving Tumor Necrosis Factor Inhibitor Therapy for Concomitant Autoimmune Diseases. Arthritis Care Res, 2017, 69(3): 449-452.
59. Carroll MB, Fields JH, Clerc PG. Rheumatoid arthritis in patients with HIV: management challenges. Open Access Rheumatol, 2016, 8: 51-59.
60. Marcelin AG, Aaron L, Mateus C, et al. Rituximab therapy for HIV-associated Castleman disease. Blood, 2003, 102(8): 2786-8.
61. Paparizos V, Rallis E, Kirsten L, Kyriakis K. Ustekinumab for the treatment of HIV. J Dermatolog Treat, 2012, 23(6): 398-9.
62. Aboulafia DM, Bundow D, Wilske K, Ochs UI. Etanercept for the treatment of human immunodeficiency virus-associated psoriatic arthritis. Mayo Clin Proc, 2000, 75(10): 1093-8.
63. Duvic M, Crane MM, Conant M, et al. Zidovudine improves psoriasis in human immunodeficiency virus-positive males. Arch Dermatol, 1994, 130: 447–451.
64. Fischer T, Schworer H, Vente C, et al. Clinical impro ve ment of HIV-associated psoriasis parallels a reduction of HIV viral load induced by effec tive antiretroviral therapy. AIDS, 1999, 13: 628–629.
65. Gavegnano C, Detorio M, Montero C et al. Ruxolitinib and tofacitinib are potent and selective inhibitors of HIV-1 replication and virus reactivation in vitro. Antimicrob Agents Chemother, 2014, 58(4): 1977-86.
Review
For citations:
Bukhanova DV, Belov BS. Joint damage in hiv positive patients. Meditsinskiy sovet = Medical Council. 2018;(9):82-87. (In Russ.) https://doi.org/10.21518/2079-701X-2018-9-82-87
Views:
8313
Email this article 